SCHEMBL7420245

SCHEMBL7420245

N#CC1CCN(C(=O)c2ccc(N)cc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 2/20 0.59
▸ CA12 O43570 2/20 0.51
▸ CA1 P00915 2/20 0.51
▸ CA2 P00918 2/20 0.51
▸ CA7 P43166 2/20 0.51
▸ CA9 Q16790 2/20 0.51
▸ CA14 Q9ULX7 2/20 0.51
▸ HSD11B1 P28845 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ L3MBTL3 Q96JM7 6/20 0.47
▸ MBTD1 Q05BQ5 4/20 0.47
▸ L3MBTL1 Q9Y468 3/20 0.47
▸ TP53BP1 Q12888 1/20 0.47
▸ L3MBTL4 Q8NA19 1/20 0.47
▸ JAK2 O60674 1/20 0.46
▸ GRM5 P41594 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24185211 0.84 MGLL (0.48) MGLLCA12CA1CA2CA7
SCHEMBL6978405 0.84 ACHE (0.63) MGLLHSD11B1MEN1KMT2AL3MBTL3
SCHEMBL20116629 0.84 KMT2A (0.61) MGLLMEN1KMT2AL3MBTL3L3MBTL1
SCHEMBL23884758 0.82 MGLL (0.46) MGLLHSD11B1MEN1KMT2AL3MBTL3
SCHEMBL31267062 0.80 MGLL (0.61) MGLLCA12CA1CA2CA7
SCHEMBL3001302 0.80 MGLL (0.61) MGLLCA12CA1CA2CA7
SCHEMBL13575475 0.80 MGLL (0.61) MGLLCA12CA1CA2CA7
SCHEMBL20261717 0.79 CA12 (0.73) MGLLCA12CA1CA2CA7
SCHEMBL12156431 0.79 ACHE (0.70) MGLLCA12CA1CA2CA7
SCHEMBL29067078 0.78 MAPT (0.71) MGLLCA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 — — EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 — — WO disclosed
Send feedback